Joshi Gagan

Joshi Gagan

Massachusetts General Hospital, Harvard Medical School
USA

I am a staff psychiatrist at the Massachusetts General Hospital (MGH) with expertise in the clinical care and research of autism spectrum disorder (ASD) and associated psychopathology in individuals throughout the life cycle, including phenotypic profile, neural and genetic underpinnings, and treatment. In addition to an active research portfolio, I provide psychiatric care to individuals of all ages who are disabled by symptoms of ASD and psychiatric comorbidity through the Bressler Program at MGH in the Pediatric Psychopharmacology Clinical and Research Program and in the Child and Adolescent Outpatient Service.

Area of Excellence: Clinical Expertise and Innovation
My clinical expertise is in the diagnosis and psychopharmacologic management of ASD and related psychopathology. I care for hundreds of children and adults with autism through the Bressler clinic and general child psychiatry clinic at the MGH. My area of expertise is in the identification and treatment of complex psychiatric comorbidity in youth and young adults with ASD, including ADHD, anxiety, and mood disorders (depression and bipolar disorder). Complicated combined pharmacotherapy is often necessary to adequately address the highly morbid clinical pictures seen in individuals with autism and psychiatric comorbidiy. I am an expert in the medical monitoring of pharmacotherapy in this vulnerable population.
My work has been instrumental in advancing the understanding that reciprocal comorbidity of ASD and psychopathology is highly under-recognized in intellectually capable populations. To improve and facilitate identification of ASD in clinical settings, I have developed diagnostic measures and algorithms for screening and rapid assessment of ASD in clinic settings and have created a web-based program for screening autism and associated psychopathology in clinically referred populations of children and adolescents.
In addition, I have contributed to the development of a Parent Medication Guide for the Management of Autism Spectrum Disorder sponsored by a collaborative effort between the the American Academy of Child and Adolescent Psychiatry (AACAP) and the American Psychiatric Association (APA).